Skip to Content

SATIVEX OROMUCOSAL SPRAY

Active substance(s): CANNABIDIOL / DELTA(9)-TETRAHYDROCANNABINOL

View full screen / Print PDF » Download PDF ⇩
Transcript
(delta-9-tetrahydrocannabinol and cannabidiol)

Package leaflet: Information for the patient

Sativex® is a registered trade mark of GW Pharma Ltd.

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

PE0018.V8

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 1 OF 27

Inside back

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Inside Front cover

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 2 OF 27

Package leaflet: Information for the patient

Sativex® Oromucosal Spray
(delta-9-tetrahydrocannabinol and cannabidiol)
Read all of this leaflet carefully before you start using this
medicine because it contains important information for you.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or
pharmacist.
• This medicine has been prescribed for you only. Do
not pass it on to others. It may harm them, even if their
signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side effects not
listed in this leaflet. See section 4
What is in this leaflet:
1. What Sativex is and what it is used for
2. What you need to know before you use Sativex
3. How to use Sativex
4. Possible side effects
5. How to store Sativex
6. Contents of the pack and other information
1

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 3 OF 27

1. What Sativex is and what it is used for
What Sativex is
Sativex is a mouth spray which contains cannabis extracts
called cannabinoids.
What Sativex is used for
Sativex is used in multiple sclerosis (MS) to improve symptoms
related to muscle stiffness. This is also called “spasticity”.
Spasticity means there is an increase in ‘muscle tone’ which
makes the muscles feel more stiff or rigid. This means it is
more difficult than normal to move the muscle.
Sativex is used when other medicines have not helped your
muscle stiffness.
Your 4 week trial of Sativex
Only a specialist doctor can start you on treatment with
Sativex.
• Before you start using Sativex your specialist doctor will do
an assessment. This is to see how bad your muscle
stiffness is. They will look at how well other treatments
have worked.
2

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 4 OF 27

• You will then have a 4 week trial of Sativex. After this, your
specialist doctor will do another assessment to see
whether Sativex is helping you.
• Only if you have shown a significant improvement in your
spasticity related symptoms after these 4 weeks should
you continue to be treated with Sativex.

2. What you need to know before you use Sativex
Do not use Sativex:
• If you are allergic to cannabis extracts or any of the
other ingredients of this medicine (listed in section 6).
• If you or anyone directly related to you has any metal
health problems such as schizophrenia, psychosis or other
significant psychiatric disorder. This does not include
depression due to your multiple sclerosis.
• If you are breast-feeding.
Do not use this medicine if any of the above apply to you.
If you are not sure, talk to your doctor or pharmacist before
using Sativex.
3

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 5 OF 27

Warnings and precautions
Talk to your doctor or pharmacist before using Sativex:
• If you are pregnant or plan to become pregnant.
• Whether male or female you must use a reliable
contraceptive method while using this medicine (see
also “Pregnancy, breast-feeding and contraception (men
and women)”’, below).
• If you are under 18 years of age.
• If you have epilepsy or regular fits (seizures).
• If you have liver or kidney problems.
• If you have a serious heart problem such as angina, a
previous heart attack, poorly controlled high blood pressure
or a problem with your heart rate or heart beat.
• If you are elderly, especially if you have problems doing
everyday activities such as making hot food and drinks.
• If you have previously abused any drug or substance.
If any of the above apply to you (or you are not sure), talk to
your doctor or pharmacist before using Sativex.
4

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 6 OF 27

Other medicines and Sativex
Tell your doctor or pharmacist if you are using or have
recently used or might use any other medicines. This is
because Sativex may affect the way some other medicines
work. Also, some other medicines can affect the way Sativex
works.
In particular, tell your doctor or pharmacist if you are using
any of the following medicines:
• Medicines that reduce anxiety (sedatives) or make you
sleep better (hypnotics). These medicines may increase the
side effects of Sativex and may increase the risks of falls
and other accidents.
• Medicines to relax your muscles such as baclofen or
diazepam. This is because taking Sativex with these
medicines may increase the risk of you falling over.
If any of the above apply to you (or you are not sure), talk to
your doctor or pharmacist before using Sativex.
If you see a different doctor or go into hospital, let them
know all the medicines you are using.
5

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 7 OF 27

Sativex with food, drink and alcohol
• In general, alcoholic beverages should be avoided whilst
using Sativex especially at the beginning of treatment or
when changing dose. If you do drink alcohol while using
Sativex, be aware that using Sativex and alcohol together
may increase their effects (such as loss of balance or ability
to respond quickly) which could increase the risk of falls
and other accidents.
• You can use Sativex with or without food (but see section 3
below “How to use Sativex”).
Pregnancy, breast-feeding and contraception (men and
women)
• If you are pregnant or breast-feeding, think you may be
pregnant or are planning to have a baby, ask your doctor or
pharmacist for advice before using this medicine.
• Do not use Sativex during pregnancy, unless advised to by
your doctor.
• Whether male or female you must use a reliable
contraceptive method while using this medicine. Keep using
it for at least 3 months after your treatment has stopped.
6

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 8 OF 27

• Do not use Sativex while breast-feeding.
If you are pregnant or breast-feeding always ask your doctor
for advice before taking any medicine.
Driving and using machines
• You must not drive or use machinery when you first start
to take Sativex and until you are established on a stable
daily dose.
• Sativex may cause you to feel sleepy or dizzy, which may
impair your judgment and performance of skilled tasks.
It has also rarely been reported to cause a brief loss of
consciousness.
• Once you are more used to taking Sativex and your dose is
stable, you should still not drive or use machinery if Sativex
causes effects such as sleepiness or dizziness that could
impair your ability to perform these tasks. If you are not
sure, do not drive or operate machines.
The medicine can affect your ability to drive as it may make
you sleepy or dizzy.
• Do not drive while taking this medicine until you know
how it affects you.
7

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 9 OF 27

• It is an offence to drive if this medicine affects your ability
to drive.
• However, you would not be committing an offence if:
o The medicine has been prescribed to treat a medical or
dental problem and
o You have taken it according to the instructions given by
the prescriber or in the information provided with the
medicine and
o It was not affecting your ability to drive safely
Talk to your doctor or pharmacist if you are not sure whether
it is safe for you to drive while taking this medicine.
Foreign travel with Sativex
Before going abroad, check that it is legal for you to take
this medicine. This includes any countries you are travelling
through.
• Sativex is a controlled drug and its legal status will vary
between countries.
• Driving while taking Sativex might be illegal in some
countries.
8

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 10 OF 27

• Please refer to page no. 22 for additional information on
foreign travel.
Sativex contains ethanol and propylene glycol
• Sativex contains about 50% v/v of ethanol (alcohol) i.e.
up to 40 mg per dose. The amount of alcohol in the
maximum daily dose for most people (12 sprays) is about
the same as found in two teaspoons (10 ml) of beer and
about one teaspoon (5 ml) of wine. This product can be
harmful for those suffering from alcoholism.
• Sativex contains propylene glycol which may cause
irritation. Symptoms of irritation are pain, itchiness, dry
cough, sore throat.

9

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 11 OF 27

3. How to use Sativex
Always use this medicine exactly as described in this leaflet
or as your doctor has told you. Check with your doctor or
pharmacist if you are not sure.
Only use Sativex in your mouth – on the inside of your cheek
or under your tongue.
• You can take Sativex with or without food. However,
taking Sativex with food can affect the amount your body
takes in. You should try, as far as possible, to take Sativex
the same way in relation to food each time, so you get the
same effect each time.

10

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 12 OF 27

Opening your spray and getting it ready to use
1. Take your spray out of the refrigerator (see section 5
for important information on Storing Sativex).
2. Write the date that you open your spray on the sticker
provided in the back of the leaflet. Stick the sticker on the
spray so that you can check the date. Do not use the spray
after it has been open for more than 6 weeks (42 days).
3. Shake the spray container gently before use.
4. Remove the protective cap.
5. Hold the spray between your thumb and second finger.
Put your first finger on the nozzle.
6. Hold the spray upright, then practice
spraying into a tissue 2 or 3 times
until a fine spray appears. These
sprays “prime” the pump and make
sure it is working properly.
7. The spray is now ready to use. You
will not need to do any more priming
sprays until you open a new spray container.
11

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 13 OF 27

Using your spray
1. Hold the spray between your thumb
and second finger. Put your first finger
on the nozzle.
2. Hold it upright and point into your
mouth. Point the nozzle under your
tongue or onto the inside of your
cheek. Change the area in your
mouth where you spray each time.
This helps to stop any discomfort in
one place.
3. Press the nozzle down firmly. Do not
take more than one spray at a time, even if you feel that
you only got a small amount of spray.
4. Replace the protective cap.

12

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 14 OF 27

If you get spray in your eyes by accident, wash them as soon
as possible with water.
• Do not breathe in the spray.
• Do not spray near children or pets.
• Do not use the spray near naked flames or heat sources.
Working out how much to use
The number of sprays you need each day depends on you as
an individual. Each person needs a different number of sprays
to give them the best relief from their muscle stiffness, with
the fewest unwanted effects.
• When you first start using Sativex, you need to follow the
days and times in the following table until you find the best
number of sprays for you.
• Stop increasing your sprays when you find the best
number of sprays for you. This may only take a few days
or it may take up to 2 weeks. Aim to use this number of
sprays each day. You can then spread your sprays evenly
over the whole day.
• Do not use more than one spray at a time. Always leave at
least 15 minutes between sprays.
13

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 15 OF 27

• Do not over-exert yourself during the first couple of days of
using Sativex until you know how it affects you.
• If you start to feel unwanted effects (usually dizziness) use
one less spray each day until you find the best symptom
relief with the fewest unwanted effects.
• When you find the best number of sprays for you, aim to
use this number each day. You can then spread your sprays
out evenly over the whole day, in a way that suits you. Still
leave at least 15 minutes between sprays.

14

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 16 OF 27

Number of sprays
Morning
Evening
Total
(between waking-up
(between 4 pm
sprays
and 12 noon)
and bedtime)
each day
Day 1
1
0
1
Day 2
1
0
1
Day 3
2
0
2
Day 4
2
0
2
Day 5
3
1
2
Day 6
4
1
3
Day 7
5
1
4
Day 8
6
2
4
Day 9
7
2
5
Day 10
8
3
5
Day 11
9
3
6
Day 12
10
4
6
Day 13
11
4
7
Day 14
12
5
7
Do not use more than 12 sprays in one day, unless your doctor tells you to.
15

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 17 OF 27

If you use more Sativex than you should
If you accidentally use more of this medicine than you
normally do you may:
• See or hear things that are not there (hallucinations).
• Feel dizzy, sleepy or confused.
• Feel your heart rate change.
• Please tell your doctor or pharmacist if you used more
Sativex than you should.
If you forget to use Sativex
• If you forget a dose, use a spray as soon as you remember
or when you feel you need a spray.
• Do not use 2 sprays at the same time to make up for a
missed spray.
Knowing if your spray is nearly empty
After the 3 priming sprays, your spray contains up to 90
measured sprays. When the spray is becoming empty, the
noise of the spray action may change. You may also find the
spray feels different in your mouth. This is because your spray
is nearly empty. When this happens you should open a new
spray container.
16

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 18 OF 27

If you stop using Sativex
If for any reason you decide to stop using Sativex, tell
your doctor or pharmacist. If you stop using your medicine
suddenly your sleep, appetite or feelings might be affected
for a short time. Your muscle stiffness usually comes back
gradually if you stop using Sativex.
If you have any further questions on the use of this medicine,
ask your doctor or pharmacist.

4. Possible side effects
Like all medicines, this medicine can cause side effects,
although not everybody gets them. These are more likely
when you start your treatment. In most cases side effects
are quite mild and they generally wear off within a few days,
please use less sprays or stop using Sativex until you feel
normal again. When you start using the medicine again, go
back to the number of sprays where you did not feel these
unwanted effects.
If you get any side effects, talk to your doctor or pharmacist.
This includes any side effects not listed in this leaflet.
17

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 19 OF 27

If you get any of the following side effects please stop taking
the medicine and contact your doctor:
• Difficulty speaking.
• Blurred vision.
• Problems with your memory or having trouble
concentrating.
• Feeling over excited or losing touch with reality.
• Feeling depressed or confused.
• Seeing or hearing things that are not there (hallucinations).
• Believing ideas that are not true.
• Feeling that other people are against you.
• Thoughts of suicide.
• Changes in pulse rate, heart rate or blood pressure.
Very common (affecting more than 1 in 10 people)
• Feeling dizzy or tired.
Common (affecting less than 1 in 10 people)
• Feeling sleepy or giddy.
• Eating more or less than usual.
• Changed sense of taste or a dry mouth.
• Constipation or diarrhoea.
18

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 20 OF 27

• Feeling or being sick.
• Mouth problems, including burning, pain or mouth ulcers.
• Lack of energy or feeling weak or generally unwell.
• Feeling abnormal or drunk.
• Loss of balance or falling over.
Uncommon (affecting less than 1 in 100 people)
• Fainting.
• Sore throat or throat irritation.
• Tummy pain.
• Mouth or teeth changing colour.
• Irritation where Sativex is sprayed.
• Red and swollen mouth or peeling inside it. Do not keep
spraying onto these areas.
Reporting of side effects
If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side effects not listed
in this leaflet. You can also report side effects directly via
United Kingdom Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard
19

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 21 OF 27

By reporting side effects you can help provide more
information on the safety of this medicine.

5. How to store Sativex
• Keep this medicine out of the sight and reach of children.
• Do not use this medicine after the expiry date shown on
the product packaging. The expiry date refers to the last
day of that month.
• Store unopened Sativex upright in its carton in a
refrigerator (2°C to 8°C). If it is not stored in a refrigerator
it will become unstable and is unlikely to work.
• Store opened Sativex in an upright position below 25°C.
• Do not use Sativex after it has been open for 42 days.
• Do not throw away any medicines via wastewater or
household waste. Ask your pharmacist how to throw away
medicines you no longer use. These measures will help
protect the environment.

20

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 22 OF 27

6. Content of the pack and other information
What Sativex contains
• The active substances are cannabis extracts. Each millilitre
(ml) contains 38-44 mg and 35-42 mg of two extracts (as
soft extracts) from Cannabis sativa L., leaf and flower,
corresponding to 27 mg/ml delta-9-tetrahydrocannabinol
(THC) and 25 mg/ml cannabidiol (CBD). Each 100 microlitre
spray contains 2.7 mg THC and 2.5 mg CBD.
• The other ingredients (excipients) are ethanol, propylene
glycol and peppermint oil.
What Sativex looks like and contents of the pack
Sativex is a yellow/brown liquid in a 10 ml glass spray
container with a pump. The pump is protected with a plastic
cap.
The number of measured sprays in the container is up to
90 sprays (after 3 priming sprays).
Sativex is packed as single, 2, 3, 4, 5, 6, 10 or 12 spray
containers in each carton.
Not all pack sizes may be marketed.
21

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 23 OF 27

Marketing Authorisation Holder and Manufacturer
GW Pharma Limited, Histon, Cambridge UK, CB24 9BZ
Foreign travel with Sativex
Check that it is legal for you to take this medicine into any
countries you are travelling to and countries you are travelling
through.
Sativex is a Controlled Drug and therefore its legal status will
vary between countries.
Driving while taking Sativex might be illegal in some
countries.
When you leave the United Kingdom, you will not need a
Home Office licence if you are travelling for less than three
months or carrying no more than three months supply of
medicine. However, you will need to carry a letter from your
doctor that has your name, address and date of birth on it.
It will need to show outward and return dates of travel, the
countries you are visiting and the medicine you are carrying.
It will need to detail the strength of the medicine and the
total amount you have with you.
When you travel abroad, contact the Embassy/Consulate/
22

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 24 OF 27

High Commission of the country you are travelling to for the
rules for that country concerning Controlled Drugs.
Information on these is given at:
http://homeoffice.gov.uk/drugs/licensing/personal/
Other formats
To listen to or request a copy of this leaflet in Braille, large
print or audio please call, free of charge:
0800 198 5000 (UK only)
Please be ready to give the following information:
Product name: Sativex Oromucosal Spray
Reference number: 18024/0009
Distributed in the UK by Bayer plc, Bayer House, Strawberry
Hill, Newbury, Berkshire, RG14 1JA.
For further medical information on how to use Sativex please
contact:
Telephone: +44 (0) 1635 563000
e-mail: medical.information@bayer.co.uk
This leaflet was last revised in 10/2015
Sativex® is a registered trade mark of GW Pharma Ltd.
23

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 25 OF 27

24

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 26 OF 27

Item Code
Proof Status

Black + 10% &
5% tints

PE0018.V8
P1/ M1

PMS 2955 C
+ (Vignette)

PMS 2622 C
+ (Vignette)

PMS Cool
Gray 3 C

Keyline
(does not print)

GW Pharma - Version 1 - August 2015

Description
Sativex® UK Patient Leaflet
Market
UK
Language
English
Component
Booklet
No. of Colours
4
Profile
As Supplied
Dimensions
95 x 85 mm
Point of Sale Code N/A
Pharmacode
N/A
Production Site No. PE0018.V8
Production Site
TBC

Artwork Originated on
Artwork Originated by
Artwork Originated at
Artwork Amended by
Artwork Amended on
TEXT SIZES
Main Body Text
Line Spacing

20/08/2015
Operator 002
ARK
Operator 000
00/00/2015

8.5pt
10.2pt

FONTS USED
Univers Light, Light Italic and Bold

Artwork Approval Signature Box
Ark Proofreader
Site Packaging
GW Pharma Approval

ARK

Crown House Business Centre
Home Gardens, Dartford
Kent DA1 1DZ
PHARMA GRAPHICS Tel +44(0)1322 424656

PAGE 27 OF 27

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide